The evolution of regulatory elements in the emerging promoter variant strains of HIV-1

• Published in: bioRxiv
• Main Authors: Bhange, Disha, Prasad, Nityanand, Singh, Swati, Prajapati, Harshit Kumar, Maurya, Shesh Prakash, Gopalan, Bindu Parachalil, Nadig, Sowmya, Devidas Chaturbhuj, Boobalan, Jayaseelan, Thongadi Ramesh Dinesha, Ahamed, Syed Fazil, Mehta, Kavita, Gohil, Yuvrajsinh, Balakrishnan, Pachamuthu, Das, Bimal Kumar, Dias, Mary, Raman Gangakhedkar, Mehendale, Sanjay, Paranjape, Ramesh, Shanmugam Saravanan, Shet, Anita, Solomon, Sunil Suhas, Thakar, Madhuri, Udaykumar Ranga
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 28.04.2021; Cold Spring Harbor Laboratory
• Edition: 1.4
• Subjects: Activator protein 1; Antiretroviral therapy; Binding sites; Gene expression; HIV; Human immunodeficiency virus; Latency; Microbiology; NF-κB protein; Regulatory sequences; Tat protein; Transcription factors; HIV-1; evolution; subtype C; sequence duplication; latency
• ISSN: 2692-8205; 2692-8205
• DOI: 10.1101/2021.04.28.441760

In a multicentric, observational, investigator-blinded, and longitudinal clinical study of 764 ART-naïve subjects, we identified nine different promoter-variant strains of HIV-1 subtype C (HIV-1C) emerging in the Indian population, with some of these variants being reported for the first time. Unlike several previous studies, our work here focuses on the evolving viral regulatory elements, not coding sequences. The emerging viral strains contain additional copies of the existing transcription factor binding sites (TFBS), including TCF-1α/LEF-1, RBEIII, AP-1, and NF-κB, created by sequence duplication. The additional TFBS are genetically diverse and may blur the distinction between the modulatory region of the promoter and the viral enhancer. In a follow-up analysis, we found trends, but not significant associations between any specific variant promoter and prognostic markers, probably because the emerging viral strains might not have established mono infections yet. Illumina sequencing of four clinical samples containing a co-infection indicated the domination of one strain over the other and establishing a stable ratio with the second strain at the follow-up time-points. Since a single promoter regulates viral gene expression and constitutes the master regulatory circuit with Tat, the acquisition of additional and variant copies of the TFBS may significantly impact viral latency and latent reservoir characteristics. Further studies are urgently warranted to understand how the diverse TFBS profiles of the viral promoter may modulate the characteristics of the latent reservoir, especially following the initiation of antiretroviral therapy. Competing Interest Statement The authors have declared no competing interest.